Management of Atrial Fibrillation
Date Added:
November 18, 2024
Journal/Publication:
JAMA
Publisher:
American Medical Association
Publication Date:
November 14, 2024
Type:
Meta-analyses, Reviews, and Guidelines
Format:
Article
DOI (1):
10.1001/jama.2024.19565
PMID (1):
39541112
Abstract
Atrial fibrillation has a lifetime prevalence of 15% to 40% and predisposes patients to stroke and cardiac dysfunction. This JAMA Clinical Guidelines Synopsis focuses on recommendations for long-term management of AF, including new paradigms for rhythm control and stroke risk reduction.
Text Availability
Free full text
RPR Commentary
2023 guidelines from the ACC/AHA/ACCP/HRS on treatment of patients with atrial fibrillation. James W. Mold, MD, MPH